Cargando...
Clinical potential of pacritinib in the treatment of myelofibrosis
Myelofibrosis (MF) is a myeloid disorder caused by a clonal hematopoietic stem-cell proliferation associated with activation of the Janus kinase (JAK) signal transducer and activator of transcription (STAT) signaling pathways. Patients with MF often develop severe splenomegaly, marked symptom burden...
Guardado en:
| Publicado en: | Ther Adv Hematol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SAGE Publications
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4530369/ https://ncbi.nlm.nih.gov/pubmed/26288713 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620715586527 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|